Proximity Extension Assay: Olink Proteomics

Enabling high-throughput and increased scalability through the analysis of thousands of proteins simultaneously.

Source Genomics - First UK-based commercial service provider of Olink Proteomics

Olink uses innovative Proximity Extension Assay (PEA) technology to measure large numbers of proteins, supporting high-quality biomarker discovery. By combining the PEA protein technology with NGS, Olink allows researchers to conduct high-throughput proteomics without compromising specificity and sensitivity of the assay. This breakthrough in genomic analysis technologies requires minimal sample, less than a drop of blood, while maintaining specificity and sensitivity at the highest level.

25802 Olink webpage graphic (1)

For more information or if you would like support with a bespoke project, please contact a member of our team or call.

Applications of Olink Proteomics PEA Technology

Olink Explore panels are categorised into four disease areas: Cardiometabolic, Inflammation, Neurology and Oncology, elevating the potential for biomarker discovery in a wide range of health and disease landscapes.

  • Identification of novel drug targets
  • Disease prediction and patient stratisfication
  • In Vivo/In Vitro Testing in Preclinical Research
  • Aid Understanding of Real-Time Human Biology

Source Genomics X Olink Proteomics Masterclass Webinar

If you're looking to delve into protein biomarker studies, make sure to watch our on demand Source Genomics X Olink Proteomics Masterclass linked below.

Talk to us about your requirements today. We are here to help you reach your research goals quickly and efficiently.

Contact us today

For more information or if you would like support with a bespoke project, please contact a member of our team or call
+44 (0) 115 973 9012

Client Portals
Select area of
interest to log in